The drug manufacturer Eli Lilly is admitting today that their drug Strattera prescribed to treat ADHD and hyperactivity causes children to have suicidal thoughts. This is after the FDA requested that Eli Lilly provide the data that they apparently had not disclosed showing the link between suicide and this ADHD drug. After reviewing this information the FDA seems to have requested that Strattera carry a warning on it’s label.
Staterra is often prescribed for ADD / ADHD or hyperactivity when teachers or parents find their children unmanageable. Strattera is also said to have side effects like suicidal thoughts.